As the global economy mends, the 2021 growth of Depression Treatment Device will have significant change from previous year. According to our (LP Information) latest study, the global Depression Treatment Device market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Depression Treatment Device market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Depression Treatment Device market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Depression Treatment Device market, reaching US$ million by the year 2028. As for the Europe Depression Treatment Device landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Depression Treatment Device players cover Flow Neuroscience AB, Ginger, Electromedical Products International, Inc., and Neuronetics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Depression Treatment Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Transcranial Direct Current Stimulation (tDCS)
Transcranial Alternating Current Stimulation (tACS)
Transcranial Pulsed Current Stimulation (tPCS)
Transcranial Random Noise Stimulation (tRNS)
Electroconvulsive therapy (ECT)
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Flow Neuroscience AB
Ginger
Electromedical Products International, Inc.
Neuronetics
Alpha-Stim
Fisher Wallace Laboratories
Neurolief
INNOVATIVE NEUROLOGICAL Devices LLC
Magnus Medical
Flow Neuroscience
BrainsWay
Caputron Medical
NeuroStar
The Magstim Company Limited